<DOC>
	<DOCNO>NCT01919359</DOCNO>
	<brief_summary>Nutritional supplementation effective placebo reduction redness bruise follow facial ablative laser resurface treatment follow soft tissue filler injection lips and/or malar area .</brief_summary>
	<brief_title>A Study Nutritional Supplementation Altering Ecchymosis , Erythema Health Outcomes Associated With Aesthetic Procedures</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Ecchymosis</mesh_term>
	<criteria>Inclusion Criteria 1 . Males female age 18 great . 2 . Subjects request full facial ablative laser resurface treatment soft tissue filler augmentation lips and/or malar area . 3 . Subjects willing abstain exclusionary procedure treatment area ( i.e. , injectable filler , laser chemical resurfacing , botulinum toxin type A , facial cosmetic surgery ) . 4 . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . 5 . Subjects childbearing potential must negative urine pregnancy test result Visit 1 willing able use acceptable method birth control ( e.g. , barrier method use spermicidal agent , hormonal method , IUD , surgical sterilization , abstinence ) study . Women consider childbearing potential one follow document medical history : postmenopausal least 12 month prior study drug administration without uterus and/or ovary bilateral tubal ligation least 6 month prior study drug administration . absence physical condition accord PI 's discretion 6 . Willingness ability provide write photo consent adherence photography procedure ( i.e. , removal jewelry makeup ) . 7 . Willingness ability provide write informed consent prior performance study related procedure . Exclusionary Criteria 1 . Subjects pregnant , nursing , plan become pregnant , and/or use reliable form birth control . 2 . Subjects know allergy sensitivity component study treatment anesthesia . 3 . Subjects prior exposure permanent filler area ( ) treat . 4 . Ablative skin resurface malar area within previous 6 month . 5 . Current history nutritional supplementation ( 14 day washout period ) 6 . Retinoid , microdermabrasion , prescription level glycolic acid treatment malar area within 2 week prior study participation study . 7 . Active infection malar area ( e.g. , acute acne lesion ulcer ) . 8 . Current history chronic drug alcohol abuse . 9 . History autoimmune disease . 10 . Current history blood thinner ( aspirin , ibuprofen , naprosyn , herbal supplement , Vitamin E , etc . ) 11 . Current history tobacco use 12 . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study medication . 13 . Subjects anticipate need surgery overnight hospitalization study . 14 . Subjects , Investigator 's opinion , history poor cooperation , nonÂ¬compliance medical treatment unreliability . 15 . Enrollment active study involve use investigational device drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>ablative laser</keyword>
	<keyword>soft tissue filler</keyword>
</DOC>